Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-12-15 to 2023-12-18
Current total value of award: $446.39
Description: 4563141647!ORALAIR 300 IR SUBLINGUAL TAB 30S